Exact Mass: 424.1192
Exact Mass Matches: 424.1192
Found 134 metabolites which its exact mass value is equals to given mass value 424.1192
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-[[4-[2-Hydroxy-2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
Sotagliflozin
6-Hydroxy-6a,12a-dehydro-alpha-toxicarol
demethylkotanin
A member of the class of 8,8-bicoumarins that is kotanin in which the methoxy group at position 7 is replaced by a hydroxy group. A fungal metabolite, its isolation from Aspergillus clavatus was first reported in 1971.
Cys Asp Ser Thr
Cys Asp Thr Ser
Cys Glu Ser Ser
Cys Ser Asp Thr
Cys Ser Glu Ser
Cys Ser Ser Glu
Cys Ser Thr Asp
Cys Thr Asp Ser
Cys Thr Ser Asp
Asp Cys Ser Thr
Asp Cys Thr Ser
Asp Ser Cys Thr
Asp Ser Thr Cys
Asp Thr Cys Ser
Asp Thr Ser Cys
Glu Cys Ser Ser
Glu Ser Cys Ser
Glu Ser Ser Cys
Ser Cys Asp Thr
Ser Cys Glu Ser
Ser Cys Ser Glu
Ser Cys Thr Asp
Ser Asp Cys Thr
Ser Asp Thr Cys
Ser Glu Cys Ser
Ser Glu Ser Cys
Ser Ser Cys Glu
Ser Ser Glu Cys
Ser Thr Cys Asp
Ser Thr Asp Cys
Thr Cys Asp Ser
Thr Cys Ser Asp
Thr Asp Cys Ser
Thr Asp Ser Cys
Thr Ser Cys Asp
Thr Ser Asp Cys
Gedocarnil
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics
Thiazolidine, 3-([1,1-biphenyl]-4-ylsulfonyl)-2-[4-(dimethylamino)phenyl]- (9CI)
LX-4211
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor
7-(2-MORPHOLIN-4-YL-ETHOXY)-2-(4-NITROPHENYL)IMIDAZO[2,1-B][1,3]-BENZOTHIAZOLE
1-(1-{[3-(Methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4-piperidin]-5-yl)methanamine
3-(2-benzofuranyl)-N-(4-nitrophenyl)-1-phenyl-4-pyrazolecarboxamide
1,2,3,4-Tetrahydroacridine-9-carboxylic acid [2-(3-chloro-4-methoxyanilino)-2-oxoethyl] ester
N-[(1,3-dioxo-2-phenyl-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl)methyl]-4-methylbenzenesulfonamide
alpha-3,4-dehydro-3,4,5-trideoxy-Kdo-(2->8)-alpha-Kdo
2-(9-hydroxy-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[1-hydroxy-2-(9-hydroxy-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
2-(9-hydroxy-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl (E)-3-(2,4-dihydroxyphenyl)prop-2-enoate
N-[[(2R)-5-chloro-7-pyridin-4-yl-2,3-dihydro-1-benzofuran-2-yl]methyl]-3,5-dimethoxybenzamide
Dapagliflozin impurity
Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor[1].